Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.

Clinical lung cancer - 1 Jul 2015

Chen Juan, Yin Ji-Ye, Li Xiang-Ping, Wang Ying, Zheng Yi, Qian Chen-Yue, He Hui, Fang Chao, Wang Zhan, Zhang Yu, Xiao Ling, Wang Sai-Ying, Zhang Wei, Zhou Hong-Hao, Liu Zhao-Qian

Abstract excerpt

BACKGROUND: Platinum-based chemotherapy is the main treatment method for lung cancer patients. The genetic polymorphisms of Wnt-inducible signaling pathway protein 1 (WISP1) were reported to be associated with the development of diverse lung diseases. In this study, we aimed to investigate the relationship of WISP1 genetic polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Non-Small-Cell Lung

Share to Lung Neoplasms

Share to Platinum Compounds

Share to Proto-Oncogene Proteins

Share to Treatment Outcome

Source

Identifiers

PMID: 25656821
DOI: 10.1016/j.cllc.2014.12.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.PMID 25656821Read ↗

WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.Semantic proximity Read ↗

Association of WNT-1 Inducible Signaling Pathway Protein-1 (WISP1) Genetic Polymorphisms with the Risk of Gastric Cancer in Guangxi ChineseSemantic proximity Read ↗

Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.Semantic proximity Read ↗

Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.Semantic proximity Read ↗

Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.Semantic proximity Read ↗

Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.Semantic proximity Read ↗

Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibilitySemantic proximity Read ↗

Wnt signaling as potential therapeutic target in lung cancerSemantic proximity Read ↗

Clinical relevance of genetic polymorphisms in WNT signaling pathway (SFRP1, WNT3A, CTNNB1, WIF-1, DKK-1, LRP5, LRP6) on pulmonary tuberculosis in a Chinese population.Semantic proximity Read ↗

Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.Semantic proximity Read ↗

Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation.Semantic proximity Read ↗

SSRP1 Promotes Lung Cancer Progression by Blocking the WNT Pathway and is Negatively Regulated by miRNA-28-5pSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.